Investor Consent. From time to time so long as the Investor 75% Event shall not have occurred, without the prior written consent of the Investor, the Company shall not take (and the Company Board shall not authorize the Company to take) any of the following actions:
Investor Consent. Until the Fall-Away of Investor Board Rights, without the prior written consent of the FP Investor Parties, the Company shall not take (and the Board shall not authorize the Company to take) any of the following actions:
Investor Consent. The purchase and sale of the Servicing Rights are subject to approval by the applicable Investors. In accordance with the Applicable Requirements, Seller shall submit to the Investors all materials necessary to obtain the Investor Consents in a timely manner with respect to the transfer of the Servicing Rights from Seller to Purchaser. Seller shall use its best efforts to obtain Investor Consents promptly, and Purchaser shall cooperate with Seller in obtaining the Investor Consents. Seller shall pay any and all costs of securing Investor Consents for the transactions contemplated in this Agreement, including, without limitation, fees to the Investors for the transfer of the Servicing Rights in accordance with the Applicable Requirements.
Investor Consent. Further to (and, for so long as such certificates remain outstanding and effective, and not in duplication of) Section 20 of the Series A-1 Certificate and Series A-2 Certificate, for so long as the Approved Holders Beneficially Own at least (i) 10% of the total number of outstanding shares of Common Stock (on an “as-converted basis”) or (ii) at least 15% of the number of shares of Series A Preferred Stock Beneficially Owned by the Initial Investors as of the Closing (as adjusted to appropriately reflect any stock split, combination, reclassification, recapitalization or similar transaction), without the prior affirmative vote or written consent of the Approved Holder Majority, the Company shall not, and (to the extent applicable) shall not permit any Subsidiary to (directly or indirectly, by the way of merger, consolidation, reclassification or otherwise):
Investor Consent. (a) For so long as the Approved Holders Beneficially Own at least (i) 10% of the total number of outstanding shares of Common Stock (on an “as-converted basis”) or (ii) at least 15% of the number of shares of Series A Preferred Stock Beneficially Owned by the Initial Investors as of the Closing (as adjusted to appropriately reflect any stock split, combination, reclassification, recapitalization or similar transaction), without the prior affirmative vote or written consent of the Approved Holder Majority, the Company shall not, and (to the extent applicable) shall not permit any Subsidiary to (directly or indirectly, by the way of merger, consolidation, reclassification or otherwise):
Investor Consent. The Approved Holders shall be entitled to the rights set forth in Section 20 of the Series A-1 Certificate of Designations even if such Series A-1 Certificate of Designations is then no longer in effect.
Investor Consent. (a) As long as the Investor Parties continue to beneficially own any shares of Series C Preferred Stock issued to the Investor on the Closing Date and, following such time as the Investor Parties no longer own any shares of Series C Preferred Stock, and in the case of clause (iii), for so long as the Investor Parties continue to hold any Common Shares issued upon conversion of such shares of Series C Preferred Stock, without the prior written consent of the Investor, the Company shall not take (and the Board shall not authorize the Company to take) any of the following actions:
Investor Consent. Notwithstanding anything to the contrary herein, as long as the Investor and its Affiliates (where such Affiliates have received Investor Shares through a transfer permitted under Section 3.01(e)) beneficially own at least ten percent (10%) of the then outstanding Company Shares, neither the Company nor the Board of Directors shall (whether in a single transaction or a series of related transactions, and whether directly or indirectly, or by amendment, merger, consolidation, or otherwise), without first obtaining the consent of the Investor;
Investor Consent. For purposes of this Contract, “Investor Consent” means concurrence of more than sixty-five percent (65%) of the Investors, as measured by each Investor’s pro rata share of capital invested in the MST Project. The Lead Provider shall be responsible for notifying the Investors within the time frames set forth in the Investment Documents regarding any matter for which Investor Consent is required under this Contract by providing the Investors with a description of the matter submitted for Investor Consent. The Investors shall provide written notice (including email notice) to the Lead Provider of whether or not Investor Consent has been obtained regarding such matter as soon as possible, but in all events within ten (10) Business Days from the date of receipt of all information that the Investors may reasonably request in order to provide such Investor Consent. The failure of the Investors to provide Investor Consent within such period of time shall constitute withholding of Investor Consent.
